Skip to content
Search

Latest Stories

WHO unveils comprehensive guidelines to help millions quit tobacco

WHO unveils comprehensive guidelines to help millions quit tobacco
The new WHO guidelines on tobacco cessation aims to enhance global access to effective cessation aids, underscoring WHO's commitment to addressing disparities in healthcare access

"Combining pharmacotherapy with behavioural interventions significantly increases quitting success rates," new World Health Organization (WHO) guidelines on tobacco cessation highlight.

In a landmark move, the WHO has unveiled comprehensive guidelines to assist the more than 750 million people worldwide seeking to quit tobacco use.


This first-ever guideline on tobacco cessation advocates for a holistic approach, integrating behavioural support, digital interventions, and pharmacological treatments to address the  global health issue.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted the significance of these guidelines in the ongoing battle against tobacco-related diseases.

"This guideline marks a crucial milestone in our global battle against these dangerous products," he stated.

"It empowers countries with the essential tools to effectively support individuals in quitting tobacco and alleviate the global burden of tobacco-related diseases.."

Despite the widespread desire to quit tobacco, according to the WHO over 70 per cent of those attempting cessation lack access to adequate support services.

This is primarily due to resource constraints within healthcare systems.

The WHO's guideline have urged governments to prioritise accessibility by offering medications such as varenicline, Nicotine Replacement Therapy (NRT), bupropion, and cytisine at reduced or no cost, particularly in low- and middle-income countries.

Since initiating a prequalification procedure for tobacco cessation medications in 2023, the WHO has recently approved Kenvue's nicotine gum and patch as the first WHO-prequalified NRT products.

This step aims to enhance global access to effective cessation aids, underscoring WHO's commitment to addressing disparities in healthcare access.

Behavioural interventions also play a crucial role in the guidelines, advocating for brief counselling sessions in healthcare settings and more intensive support through individual, group, or telephonic counselling.

Digital interventions, such as smartphone applications and online programs, are recommended as additional support tools throughout the quitting process.

Dr. Rüdiger Krech, WHO's Director of Health Promotion, emphasised the collaborative effort required to tackle tobacco use.

"These guidelines are designed to empower communities and governments to provide the best possible support for individuals on this challenging journey," he stressed.

The release of WHO's comprehensive tobacco cessation guidelines represents a significant step towards reducing the global burden of tobacco-related diseases and improving public health worldwide.

Healthcare providers, policymakers, and stakeholders are urged to adopt and implement these guidelines to support millions in achieving tobacco-free lives.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less